Abstract
The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.
Translated title of the contribution | HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF |
---|---|
Original language | English |
Patent number | 8597647 |
Publication status | Published - 1800 |